Concepts (48)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Non-Small-Cell Lung | 3 | 2018 | 333 | 0.650 |
Why?
|
| Lung Neoplasms | 3 | 2018 | 1596 | 0.420 |
Why?
|
| Radiosurgery | 3 | 2018 | 108 | 0.390 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2017 | 662 | 0.380 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 1008 | 0.330 |
Why?
|
| Neoplasms, Second Primary | 2 | 2018 | 152 | 0.260 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2018 | 1135 | 0.210 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 1233 | 0.130 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2017 | 80 | 0.130 |
Why?
|
| Macaca mulatta | 1 | 2016 | 491 | 0.120 |
Why?
|
| Whole Genome Sequencing | 1 | 2016 | 280 | 0.120 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 865 | 0.120 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 6464 | 0.100 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 869 | 0.090 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 5132 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 2089 | 0.080 |
Why?
|
| Th2 Cells | 1 | 2009 | 185 | 0.080 |
Why?
|
| Cell Lineage | 1 | 2009 | 338 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2018 | 12288 | 0.070 |
Why?
|
| Aged | 3 | 2018 | 19533 | 0.060 |
Why?
|
| Middle Aged | 3 | 2018 | 26588 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2009 | 2583 | 0.040 |
Why?
|
| Female | 4 | 2018 | 66275 | 0.040 |
Why?
|
| Male | 3 | 2018 | 60998 | 0.040 |
Why?
|
| Time Factors | 2 | 2018 | 6283 | 0.030 |
Why?
|
| Population Density | 1 | 2016 | 34 | 0.030 |
Why?
|
| Salvage Therapy | 1 | 2018 | 194 | 0.030 |
Why?
|
| Genetic Fitness | 1 | 2016 | 34 | 0.030 |
Why?
|
| Radiation Injuries | 1 | 2016 | 143 | 0.030 |
Why?
|
| Models, Animal | 1 | 2016 | 459 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2018 | 541 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 2037 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2016 | 672 | 0.030 |
Why?
|
| Humans | 3 | 2018 | 124175 | 0.020 |
Why?
|
| Disease Progression | 1 | 2016 | 2046 | 0.020 |
Why?
|
| Age Factors | 1 | 2016 | 2806 | 0.020 |
Why?
|
| GATA3 Transcription Factor | 1 | 2009 | 35 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2009 | 39 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 4780 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2629 | 0.020 |
Why?
|
| Protein Binding | 1 | 2009 | 1737 | 0.020 |
Why?
|
| Animals | 2 | 2016 | 34038 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2009 | 1890 | 0.010 |
Why?
|
| Asthma | 1 | 2009 | 747 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2009 | 3725 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2018 | 16275 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 4342 | 0.010 |
Why?
|
| Mice | 1 | 2009 | 17618 | 0.010 |
Why?
|